Alexion Pharmaceuticals Балансовая стоимость акции

Что обозначает Балансовая стоимость акции в Alexion Pharmaceuticals?

Балансовая стоимость акции Alexion Pharmaceuticals Inc. является 52.72

Какое определение для Балансовая стоимость акции?

Балансовая стоимость на акцию - это активы компании за вычетом обязательств, разделенные на количество акций в обращении.

The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.

The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.

Балансовая стоимость акции компаний в Health Care сектор на NASDAQ по сравнению с Alexion Pharmaceuticals

Что делает Alexion Pharmaceuticals?

Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines. As a leader in rare diseases for more than 25 years, Alexion has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), as well as the first and only approved complement inhibitor to treat anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD). Alexion also has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D) as well as the first and only approved Factor Xa inhibitor reversal agent. In addition, the company is developing several mid-to-late-stage therapies, including a copper-binding agent for Wilson disease, an anti-neonatal Fc receptor (FcRn) antibody for rare Immunoglobulin G (IgG)-mediated diseases and an oral Factor D inhibitor as well as several early-stage therapies, including one for light chain (AL) amyloidosis, a second oral Factor D inhibitor and a third complement inhibitor. Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on hematology, nephrology, neurology, metabolic disorders, cardiology, ophthalmology and acute care. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries.

Компании с балансовая стоимость акции похож на Alexion Pharmaceuticals



  • GE Aerospace имеет Балансовая стоимость акции из 52.62
  • Shalimar Paints имеет Балансовая стоимость акции из 52.66
  • Pipestone имеет Балансовая стоимость акции из 52.67
  • Norfolk Southern имеет Балансовая стоимость акции из 52.67
  • General Motors имеет Балансовая стоимость акции из 52.69
  • Koninklijke DSM N.V имеет Балансовая стоимость акции из 52.70
  • Alexion Pharmaceuticals имеет Балансовая стоимость акции из 52.72
  • Aptech имеет Балансовая стоимость акции из 52.72
  • Hindustan Oil Exploration имеет Балансовая стоимость акции из 52.74
  • Steel Exchange India имеет Балансовая стоимость акции из 52.74
  • Alibaba Ltd имеет Балансовая стоимость акции из 52.75
  • The Indian Wood Products имеет Балансовая стоимость акции из 52.76
  • Duolingo имеет Балансовая стоимость акции из 52.76